Prognostic value of congestive heart failure history in patients undergoing percutaneous coronary interventions

J Am Coll Cardiol. 1998 Oct;32(4):936-41. doi: 10.1016/s0735-1097(98)00339-8.

Abstract

Objectives: We sought to determine the prognostic significance of a history of congestive heart failure above that provided by baseline ejection fraction in patients undergoing percutaneous coronary interventions.

Background: Left ventricular function is a known predictor of survival in patients with coronary artery disease, as is a history of congestive heart failure. The contribution of heart failure history independent of left ventricular function is unknown.

Methods: Data were pooled from four interventional trials and the Duke University database. The combined dataset included 5,260 patients undergoing percutaneous interventions, 334 with and 4,926 without a history of heart failure. Patients were defined by the treating physician as having a clinical history of heart failure at the time of enrollment.

Results: The 30-day and 6-month mortality were higher in patients with a clinical history of congestive heart failure than in those without such a history (2% vs. <1%, p=0.002 at 30 days, 5% vs. 1%, p=0.001 at 6 months). Heart failure history did not influence the incidence of myocardial infarction, use of angioplasty or the use of bypass surgery during follow-up. Multivariable analysis revealed that heart failure history added significantly to ejection fraction in predicting intermediate-term (6-month) mortality (p=0.01). Stepwise logistic regression also revealed heart failure history to be an independent predictor of 6-month mortality (odds risk 1.9, 95% confidence interval 1.1 to 3.5).

Conclusions: A clinical history of congestive heart failure is associated with increased early and intermediate-term mortality in patients undergoing percutaneous revascularization. Congestive heart failure history appears to provide prognostic information independent of that available from a patient's left ventricular function. These findings suggest that patients with a clinical history of congestive heart failure who undergo a percutaneous intervention should be closely monitored, especially those with the lowest ejection fractions.

MeSH terms

  • Aged
  • Angioplasty, Balloon, Coronary*
  • Atherectomy, Coronary*
  • Coronary Disease / complications
  • Coronary Disease / mortality*
  • Coronary Disease / physiopathology
  • Coronary Disease / therapy
  • Female
  • Follow-Up Studies
  • Heart Failure / complications*
  • Heart Failure / physiopathology
  • Humans
  • Male
  • Middle Aged
  • Odds Ratio
  • Prognosis
  • Randomized Controlled Trials as Topic
  • Risk Factors
  • Stroke Volume
  • Survival Rate